Cargando…
The lipid-lowering effects of Danhong and Huangqi injections: a meta-analysis of clinical controlled trials
BACKGROUND: Dyslipidaemia is a major risk factor for coronary heart disease (CHD). Danhong and Huangqi injections, two traditional Chinese medicine prescriptions, have been widely studied regarding their lipid-lowering properties. However, the results were inconsistent and inconclusive. Thus, we con...
Autores principales: | Yu, Liuqin, Zhou, Chunyang, Luo, Zhi, Zeng, Wei, Lai, Feiya, Han, Gangjie, Song, Yongyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944065/ https://www.ncbi.nlm.nih.gov/pubmed/29747663 http://dx.doi.org/10.1186/s12944-018-0760-2 |
Ejemplares similares
-
Associations of the APOB rs693 and rs17240441 polymorphisms with plasma APOB and lipid levels: a meta-analysis
por: Niu, Caiqin, et al.
Publicado: (2017) -
An Overview of Meta-Analyses of Danhong Injection for Unstable Angina
por: Zhang, Xiaoxia, et al.
Publicado: (2015) -
Meta-Analysis of the Clinical Value of Danshen Injection and Huangqi Injection in Liver Cirrhosis
por: Zhu, Changtai, et al.
Publicado: (2013) -
Associations of the ABCA1 gene polymorphisms with plasma lipid levels: A meta-analysis
por: Lu, Zhan, et al.
Publicado: (2018) -
The Clinical Value of Huangqi Injection in the Treatment of Leucopenia: A Meta-Analysis of Clinical Controlled Trials
por: Zhang, Changsong, et al.
Publicado: (2013)